MR-guided focused ultrasound: Enhancement of intratumoral uptake of [ 3H]-docetaxel in vivo

Physics in Medicine and Biology

Volumn 55, Issue 24, 2010, Pages 7399-7410

  Chen, Lili ^a   Mu, Zhaomei ^a   Hachem, Paul ^a   Ma, C M ^a   Wallentine, Annie ^a   Pollack, Alan ^a,b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; FOCUSED ULTRASOUND; HUMAN PROSTATE CANCER; IN-VIVO; LIQUID SCINTILLATION COUNTER; LNCAP CELLS; NUDE MICE; PROSTATE TUMOR; SINGLE-DOSE; TAIL VEINS; TREATMENT WELLS; TUMOR GROWTH; TUMOR TISSUES;

SCINTILLATION COUNTERS; TUMORS; ULTRASONICS;

ANIMALS;

ANTINEOPLASTIC AGENT; DOCETAXEL; TAXOID; TRITIUM;

ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; DRUG SCREENING; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE TUMOR; TEMPERATURE; THERMOMETER; TIME; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; ULTRASOUND THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; PROSTATIC NEOPLASMS; TAXOIDS; TEMPERATURE; THERMOMETERS; TIME FACTORS; TRITIUM; ULTRASONIC THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78650053471     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/24/001     Document Type: Article

References (36)

1. Banerjee S, Hussain M, Wang Z, Saliganan A, Che M, Bonfil D, Cher M and Sarkar F H 2007 In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer Cancer Res. 67 3818-26
2. Bednarski M D, Lee J W, Callstrom M R and Li K C 1997 In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound Radiology 204 263-8
3. Chen L, Ma C M, Richardson T, Freedman G M and Konski A 2009a Treatment of bone metastasis using MR guided focused ultrasound Med. Phys. 36 2486
4. Chen L, Mu Z, Hachem P, Ma C M and Pollack A 2009b Enhancement of drug delivery in prostate tumor in vivo using MR guided focused ultrasound (MRgHIFU) IFMBE Proc. 25/VI: World Congress (Munich, Germany) ed W C Schlegel (Heidelberg: Springer) pp 341-4
5. Chen L, Rivens I, ter Haar G, Riddler S, Hill C R and Bensted J P 1993 Histological changes in rat liver tumours treated with high-intensity focused ultrasound Ultrasound Med. Biol. 19 67-74
6. Chen L, ter Haar G, Hill C R, Eccles S A and Box G 1998 Treatment of implanted liver tumors with focused ultrasound Ultrasound Med. Biol. 24 1475-88
7. Chen L et al 2007 MR guided focused ultrasound (MRgFU) for the treatment of prostate cancer: a feasibility study of increasing cellular uptake of AS-MDM2 in vivo Med. Phys. 34 2625
8. Cline H E, Schenck J F, Watkins R D, Hynynen K and Jolesz F A 1993 Magnetic resonance-guided thermal surgery Magn. Reson. Med. 30 98-106
9. Dittmar K M, Xie J, Hunter F, Trimble C, Bur M, Frenkel V and Li K C 2005 Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience Radiology 235 541-6
10. Engels F K, Buijs D, Loos W J, Verweij J, Bakker W H and Krenning E P 2006 Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion method Anti-Cancer Drugs 17 63-7
11. Hancock H A et al 2009 Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism Ultrasound Med. Biol. 35 1722-36
12. Hanks G E, Hanlon A L, Schultheiss T E, PinoverW H, Movsas B, Epstein B E and Hunt M A 1998 Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions Int. J. Radiat. Oncol. Biol. Phys. 41 501-10
13. Hill C R and Ter Haar G 1995 High intensity focused ultrasound: potential for cancer treatment Br. J. Radiol. 68 1296-303
14. Hynynen K 2007 Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain Expert Opin. Drug Deliv. 4 27-35 (Pubitemid 46117484)
15. Hynynen K, FreundWR, Cline H E, Chung A H,Watkins R D, Vetro J P and Jolesz F A 1996 A clinical, noninvasive, MR imaging-monitored ultrasound surgery method Radiographics 16 185-95 (Pubitemid 126448421)
16. Jacob R, Hanlon A L, Horwitz E M, Movsas B, Uzzo R G and Pollack A 2004 The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer Cancer 100 538-43
17. Jones D R et al 2010 Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion J. Thorac. Oncol. 5 75-81
18. Khaibullina A, Jang B S, Sun H, Le N, Yu S, Frenkel V, Carrasquillo J A, Pastan I, Li K C and Paik C H 2008 Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice J. Nucl. Med. 49 295-302
19. Liu H L, Hua M Y, Chen P Y, Chu P C, Pan C H, Yang H W, Huang C Y, Wang J J, Yen T C and Wei K C 2010 Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment Radiology 255 415-25
20. Ma C M, Chen L and Freedman G 2009a MR guided focused ultrasound for high risk and recurrent breast cancer IFMBE Proc. 25/VI: World Congress (Munich, Germany) ed W C Schlegel (Heidelberg: Springer) pp 140-3
21. Ma C M, Chen L and Pollack A 2009b Quality assurance for MR guided focused ultrasound as a multi-modality platform for cancer therapy Med. Phys. 36 2631
22. McDannoldN, ClementGT, Black P, Jolesz F andHynynenK2010 Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients Neurosurgery 66 323-32 discussion 32
23. Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon H W, Hanlon A L, Agrawal S and Pollack A 2008 Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo Prostate 68 599-609
24. Nelson J L et al 2002 Ultrasonically activated chemotherapeutic drug delivery in a rat model Cancer Res. 62 7280-3
25. Pollack A, Zagars G K, Antolak J A, Kuban D A and Rosen II 2002a Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial Int. J. Radiat. Oncol. Biol. Phys. 54 677-85
26. Pollack A, Zagars G K, Smith L G, Lee J J, von Eschenbach A C, Antolak J A, Starkschall G and Rosen I 2000 Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J. Clin. Oncol. 18 3904-11
27. Pollack A, Zagars G K, Starkschall G, Antolak J A, Lee J J, Huang E, von Eschenbach A C, Kuban D A and Rosen I 2002b Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int. J. Radiat. Oncol. Biol. Phys. 53 1097-105
28. Rapoport N Y, Nam K H, Gao Z and Kennedy A 2009 Application of ultrasound for targeted nanotherapy of malignant tumors Acoust. Phys. 55 594-601
29. Spigel D R et al 2010 Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer Clin. Lung Cancer 11 198-203
30. Stoyanova R, Hachem P, Hensley H, Khor L Y, Mu Z, Hammond M E, Agrawal S and Pollack A 2007 Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo Int. J. Radiat. Oncol. Biol. Phys. 68 1151-60
31. ter Haar G 2007 Therapeutic applications of ultrasound Prog. Biophys. Med. Biol. 93 111-29
32. ter Haar G R, Daniels S and Morton K 1986 Evidence for acoustic cavitation in vivo: thresholds for bubble formation with 0.75-MHz continuous wave and pulsed beams IEEE Trans. Ultrason. Ferroelectr. Freq. Control 33 162-4
33. ter Haar G, Rivens I, Chen L and Riddler S 1991 High intensity focused ultrasound for the treatment of rat tumours Phys. Med. Biol. 36 1495-501
34. Wu F, Wang Z B, Chen W Z, Zhu H, Bai J, Zou J Z, Li K Q, Jin C B, Xie F L and Su H B 2004 Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma Ann. Surg. Oncol. 11 1061-9 (Pubitemid 40486652)
35. Yuh E L, Shulman S G, Mehta S A, Xie J, Chen L, Frenkel V, Bednarski M D and Li K C 2005 Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model Radiology 234 431-7
36. Zelefsky M J, Leibel S A, Gaudin P B, Kutcher G J, Fleshner N E, Venkatramen E S, Reuter V E, Fair W R, Ling C C and Fuks Z 1998 Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 41 491-500